Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neuromuscul Disord ; 25(3): 231-7, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25633150

ABSTRACT

Becker muscular dystrophy is characterized by a variable disease course. Many factors have been implicated to contribute to this diversity, among which the expression of several components of the dystrophin associated glycoprotein complex. Together with dystrophin, most of these proteins anchor the muscle fiber cytoskeleton to the extracellular matrix, thus protecting the muscle from contraction induced injury, while nNOS is primarily involved in inducing vasodilation during muscle contraction, enabling adequate muscle oxygenation. In the current study, we investigated the role of three components of the dystrophin associated glycoprotein complex (beta-dystroglycan, gamma-sarcoglycan and nNOS) and the dystrophin homologue utrophin on disease severity in Becker patients. Strength measurements, data about disease course and fresh muscle biopsies of the anterior tibial muscle were obtained from 24 Becker patients aged 19 to 66. The designation of Becker muscular dystrophy in this study was based on the mutation and not on the clinical severity. Contrary to previous studies, we were unable to find a relationship between expression of nNOS, beta-dystroglycan and gamma-sarcoglycan at the sarcolemma and disease severity, as measured by muscle strength in five muscle groups and age at reaching several disease milestones. Unexpectedly, we found an inverse correlation between utrophin expression at the sarcolemma and age at reaching disease milestones.


Subject(s)
Dystroglycans/metabolism , Muscular Dystrophy, Duchenne/physiopathology , Nitric Oxide Synthase Type I/metabolism , Sarcoglycans/metabolism , Utrophin/metabolism , Adult , Aged , Disease Progression , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Middle Aged , Muscle Strength/physiology , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Muscular Dystrophy, Duchenne/diagnosis , Muscular Dystrophy, Duchenne/genetics , Muscular Dystrophy, Duchenne/pathology , Sarcolemma/metabolism , Sarcolemma/pathology , Severity of Illness Index , Surveys and Questionnaires , Young Adult
2.
Neuromuscul Disord ; 21(8): 569-78, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21724396

ABSTRACT

To identify serum biomarkers that allow monitoring of disease progression and treatment effects in Duchenne muscular dystrophy (DMD) patients, levels of matrix metalloproteinase-9 (MMP-9), tissue inhibitors of metalloproteinase-1 (TIMP-1) and osteopontin (OPN) were determined in 63 DMD patients on corticosteroid therapy. These proteins were selected for their role in the pathogenesis of muscular dystrophy. Levels of MMP-9 and TIMP-1 were significantly higher in sera of DMD patients compared to healthy controls, whereas the OPN levels showed no significant difference. MMP-9 levels were also observed to be significantly higher in older, nonambulant patients, compared to ambulant patients. Longitudinal data from a smaller cohort of DMD patients followed up for over 4years showed that MMP-9, but not TIMP-1 increased significantly with age. Hence, MMP-9 is a potential DMD biomarker for disease progression. Future studies have to confirm whether serum MMP-9 levels can be used to monitor therapeutic response.


Subject(s)
Disease Progression , Matrix Metalloproteinase 9/blood , Muscular Dystrophy, Duchenne/blood , Muscular Dystrophy, Duchenne/physiopathology , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Animals , Biomarkers/blood , Case-Control Studies , Child , Child, Preschool , Disease Models, Animal , Female , Humans , Longitudinal Studies , Male , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Muscular Dystrophy, Duchenne/drug therapy , Osteopontin/blood , Tissue Inhibitor of Metalloproteinase-1/blood , Treatment Outcome , Young Adult
3.
Plant Biol (Stuttg) ; 12(1): 1-12, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20653883

ABSTRACT

One of the earliest events in the process of leaf senescence is dismantling of chloroplasts. Mesophyll cell chloroplasts from rosette leaves were studied in Arabidopsis thaliana undergoing natural senescence. The number of chloroplasts decreased by only 17% in fully yellow leaves, and chloroplasts were found to undergo progressive photosynthetic and ultrastructural changes as senescence proceeded. In ultrastructural studies, an intact tonoplast could not be visualized, thus, a 35S-GFP::delta-TIP line with a GFP-labeled tonoplast was used to demonstrate that chloroplasts remain outside of the tonoplast even at late stages of senescence. Chloroplast DNA was measured by real-time PCR at four different chloroplast loci, and a fourfold decrease in chloroplast DNA per chloroplast was noted in yellow senescent leaves when compared to green leaves from plants of the same age. Although chloroplast DNA did decrease, the chloroplast/nuclear gene copy ratio was still 31:1 in yellow leaves. Interestingly, mRNA levels for the four loci differed: psbA and ndhB mRNAs remained abundant late into senescence, while rpoC1 and rbcL mRNAs decreased in parallel to chloroplast DNA. Together, these data demonstrate that, during senescence, chloroplasts remain outside of the vacuole as distinct organelles while the thylakoid membranes are dismantled internally. As thylakoids were dismantled, Rubisco large subunit, Lhcb1, and chloroplast DNA levels declined, but variable levels of mRNA persisted.


Subject(s)
Arabidopsis/growth & development , Chloroplasts/ultrastructure , Plant Leaves/growth & development , Arabidopsis/ultrastructure , DNA, Chloroplast/analysis , Microscopy, Confocal , Microscopy, Electron, Transmission , Plant Leaves/ultrastructure , RNA, Messenger/analysis , RNA, Plant/analysis , Vacuoles/metabolism
4.
Plant Physiol ; 123(1): 393-402, 2000 May.
Article in English | MEDLINE | ID: mdl-10806256

ABSTRACT

Overexpression of the HAL1 gene in yeast has a positive effect on salt tolerance by maintaining a high internal K(+) concentration and decreasing intracellular Na(+) during salt stress. In the present work, the yeast gene HAL1 was introduced into tomato (Lycopersicon esculentum Mill.) by Agrobacterium tumefaciens-mediated transformation. A sample of primary transformants was self-pollinated, and progeny from both transformed and non-transformed plants (controls) were evaluated for salt tolerance in vitro and in vivo. Results from different tests indicated a higher level of salt tolerance in the progeny of two different transgenic plants bearing four copies or one copy of the HAL1 gene. In addition, measurement of the intracellular K(+) to Na(+) ratios showed that transgenic lines were able to retain more K(+) than the control under salt stress. Although plants and yeast cannot be compared in an absolute sense, these results indicate that the mechanism controlling the positive effect of the HAL1 gene on salt tolerance may be similar in transgenic plants and yeast.


Subject(s)
Adaptation, Physiological , Fungal Proteins/genetics , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Solanum lycopersicum/physiology , Intracellular Signaling Peptides and Proteins , Solanum lycopersicum/genetics , Plants, Genetically Modified , Sodium Chloride , Transformation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...